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Background: In 2008 the World Health Organization (WHO) reported that South Africa had the highest tuberculosis
(TB) incidence in the world. This high incidence rate is linked to a number of factors, including HIV co-infection and
alcohol use disorders. The diagnosis and treatment package for TB and HIV co-infection is relatively well established
in South Africa. However, because alcohol use disorders may present more insidiously, making it difficult to
diagnose, those patients with active TB and misusing alcohol are not easily cured from TB. With this in mind, the
primary purpose of this cluster randomized controlled trial was to provide screening for alcohol misuse and to test
the effectiveness of brief interventions in reducing alcohol intake in those patients with active TB found to be
misusing alcohol in primary public health care clinics in three districts in South Africa.
Methods: Within each of the three provinces targeted, one district with the highest TB burden was selected.
Furthermore, 14 primary health care facilities with the highest TB caseload in each district were selected. In each district,
7 of the 14 (50%) clinics were randomly assigned to a control arm and another 7 of the 14 (50%) clinics assigned to
intervention arm. At the clinic level systematic sampling was used to recruit newly diagnosed and retreatment TB
patients. Those consenting were screened for alcohol misuse using the Alcohol Use Disorder Identification Test (AUDIT).
Patients who screened positive for alcohol misuse over a 6-month period were given either a brief intervention based on
the Information-Motivation-Behavioural Skills (IMB) Model or an alcohol use health education leaflet.
Results: Of the 4882 tuberculosis patients screened for alcohol and agreed to participate in the trial, 1196 (24.6%)
tested positive for the AUDIT. Among the 853 (71%) patients who also attended the 6-month follow-up session,
the frequency of positive screening results at baseline/follow-up were 100/21.2% for the AUDIT (P < 0.001) for the
control group and 100/16.8% (P < 0.001) for the intervention group. The intervention effect on the AUDIT score
was statistically not significant. The intervention effect was also not significant for hazardous or harmful drinkers
and alcohol dependent drinkers (AUDIT: 7–40), alcohol dependent drinkers and heavy episodic drinking, while
the control group effect was significant for hazardous drinkers (AUDIT: 7–19) (P = 0.035).
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Conclusion: The results suggest that alcohol screening and the provision of a health education leaflet on
sensible drinking performed at the beginning of anti-tuberculosis treatment in public primary care settings may
be effective in reducing alcohol consumption.
Trial registrations: PACTR201105000297151Background
The 2008 World Health Organization (WHO) Report
found that South Africa had the highest tuberculosis
(TB) incidence in the world, at over 5 times the average
incidence rate found in the 22 high-burden countries
[1]. In 2006, South Africa with only 0.7% of the world’s
population had an estimated 28% of HIV positive adult
TB cases reported globally [1]. Over the last 5 years TB
case notification has increased by a massive 81%, from
188 695 cases in 2001 to 341 165 cases in 2006 [1]. This
increase is mostly associated with the co-morbidity
between HIV and TB. However, other factors, such as
poverty and alcohol misuse is also associated with TB
incidence.
Excessive alcohol use has been causally linked to TB
incidence, as alcohol consumption increases the risk of
infectious disease, such as TB, considerably. Two pathways
are involved: the first is biological via weakening of the
immune system, and the second is social via social exclu-
sion and drift, resulting in about a threefold increased risk
of TB [2,3]. Alcohol use was estimated to have been
responsible for 939 000 disability-adjusted life-years
lost in South Africa for TB and HIV/AIDS alone in
2004 (253 000 for women, 687 000 for men) [2]. This
figure corresponds to 4.6% of the overall disease burden in
South Africa (2.5% for women, 6.6% for men) [2]. These
numbers show the potential for reducing alcohol-attri-
butable infectious disease burden in South Africa, since
cost-effective measures for reducing alcohol-attributable
harm in developing societies exists and could be applied [2].
There are numerous studies cited in the literature that
support the strong association between alcohol use, al-
cohol use disorders and TB [3-8]. Numerous studies show
the pathogenic impact of alcohol on the immune system
causing susceptibility to TB among drinkers [4,7,9]. “Alco-
hol use strongly influences both the incidence and the out-
come of the disease and was found to be linked to altered
pharmacokinetics of medicines used in the treatment of
TB, social marginalization and drift, higher rate of re-
infection, higher rate of treatment defaults and develop-
ment of drug-resistant forms of TB; about 10% of the TB
cases globally were estimated to be attributable to alcohol”
[3], p.1. People that drink heavily show higher relapse
rates, a higher probability of an unfavourable clinical
course and a higher probability of experiencing the most
destructive forms of TB [3,5].Hazardous drinking is defined as a quantity or pattern
of alcohol consumption that places patients at risk for
adverse health events, while harmful drinking is defined
as alcohol consumption that results in adverse events
(e.g., physical or psychological harm) [10]. In studies in
South Africa high rates of hazardous or harmful drinking
or possible alcohol dependence using the Alcohol Use
Disorder Identification Test (AUDIT) were found among
tuberculosis patients (23.2%-36%) [11,12]. Previous studies
using the same alcohol measure (the AUDIT) found lower
rates of hazardous or harmful alcohol use or possible alco-
hol dependence in general public primary care patients in
South Africa 19.2% [13] and 19.2% [14] and in a national
population-based survey in South Africa 9% [15].
Screening and brief interventions for alcohol
use disorders
Increasing emphasis has been placed on the detection
and treatment of hazardous and harmful drinking disor-
ders, particularly among patients who are seen in primary
health care settings [11]. Screening instruments such as
the AUDIT, CAGE (Cut Down, Annoyed, Guilty and Eye
Opener), and Screening and Brief Interventions (SBIs)
have been found to be useful in detecting and treating
alcohol use disorders in a number of settings [13,16,17].
The interventions are based on cognitive-behavioural in-
terventions and motivational interviewing techniques and
have been found to be effective and efficient in the treat-
ment of alcohol use disorders in most chronic conditions.
In previous studies screening and brief intervention for
alcohol problems have been successfully implemented by
nurses in demonstration projects in South Africa as part
of a WHO strategy to expand screening and brief inter-
vention for alcohol problems in developing countries
funded by WHO and NIAAA [16,18]. Community health
workers have been identified as strategic implementation
agents for screening and brief intervention of alcohol
problems in primary care in South Africa [16].
Whilst there have been studies conducted on screening
for alcohol misuse and brief interventions producing
favourable results [19,20], there is a dearth of scientific
literature on evidence-based best practice methods to
screen for alcohol misuse and brief interventions amongst
individuals with active TB [21]. In South Africa the target
rate set by the WHO for TB cure has not been met, and
the fact that alcohol use and misuse is known to be one of
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interrogate behavioural models that address reduction in
alcohol consumption. Given that the sample for the
current study was from three districts with the highest TB
burden in South Africa, reducing alcohol consumption
will be valuable in that, it will reduce the participants’
vulnerability to unfavourable TB treatment outcomes,
such as treatment failure, a high treatment default rate,
TB re-infection and the development of resistant forms
of TB. Thus reducing the incidence rate for the population
at large.
Aim of the study
The aim of this study was to conduct a cluster random-
ized control trial to assess the effectiveness of SBI for
alcohol use disorders among TB patients in public pri-
mary care clinics. Consenting patients who started TB
treatment and screened for risky consumption of alcohol
using a standardized tool were randomized, with the
public primary care clinic being the unit of ran-
domization into one of two arms: The first arm being a
Brief Intervention for alcohol misuse arm (treatment
arm) and the second arm being the treatment as usual
in addition to receiving an alcohol education leaflet
(control arm). We hypothesized that compared to the
control group, patients receiving brief alcohol interven-
tion in the intervention group would reduce the overall
AUDIT score and would increase screening negative on
the AUDIT. The null hypothesis of the study was that
the mean AUDIT scores and those screening negative on
the AUDIT between those in the intervention and control
groups will not be statistically significantly different.
Methods
Setting
Three provinces, in South Africa, with the highest TB
caseload were selected for inclusion in the study. One
district in each province (N = 3) with the highest TB
caseloads were consequently included. These districts
were Siyanda in the Northern Cape Province, Nelson
Mandela Metro in the Eastern Cape Province, and
eThekwini in KwaZulu-Natal Province. Within each of
these three study districts 14 public primary health care
facilities were selected based on the highest TB case-
loads per clinic (N = 42). The type of health facility was
a primary health care clinic or community health centre.
The study catchment areas within the study health dis-
tricts and randomization procedures enabled a broad
coverage of major population groups.
Design
In order to assess the effectiveness of the Screening and
Brief Interventions (SBI) among tuberculosis patients
found to be misusing alcohol, a cluster randomizedcontrolled trial design was implemented. All new TB and
retreatment patients were screened using the AUDIT.
TB patients who met the cut-off for misusing alcohol both
in the intervention and control arms were reassessed after
baseline assessment at time 2 (3 months following in-
tervention) and time 3 (6 months following intervention).
The intervention comprised the following: personalized
feedback on AUDIT results, a health education leaflet,
simple advice and brief counselling about reducing ex-
cessive drinking, during one −20 minute- session. The trial
incorporated cluster randomization of public primary
health care facilities to avoid the risk of contamination.Principles for recruitment
Inclusion criteria
Public primary health care clinics Clinics with a high
TB caseload (based on statistics provided by the Depart-
ment of Health) in each of the three study districts with
a high burden of TB were included in the study.
Patients with active TB New tuberculosis and retreat-
ment patients (i.e. those patients who have been initiated
or have been on anti-TB treatment for less than one
month), males and females, 18 years and above who vis-
ited the primary health care facility and who scored 8 or
more for men and 7 or more for women on the AUDIT
questionnaire after the screening were included in this
study. A few studies have reported that brief interventions
are effective even among excessive drinkers [22-24].
Therefore patients scoring high on the AUDIT were also
included in the study. Under 18 years of age were ex-
cluded since in South Africa the legal minimum age for al-
cohol use is 18 years and the study aimed at providing an
intervention for hazardous, or harmful drinking or alcohol
dependence.Randomisation
Randomisation was conducted using a secure remote
randomization service. Within each district in each of
the three provinces the 14 public primary health clinics
with the highest TB caseloads were randomly assigned
to the treatment and control arms. A secure remote ran-
domisation service carried out randomisation. Twenty
one allocations were initially generated for each of the
possible factorial combinations of clinic type, TB case
load, and intervention. Randomisation was stratified by
clinic type (clinic and community health centre) and TB
case load. The standby and reallocated clinics were sub-
sequently randomly allocated in a similar manner. TB
patients misusing alcohol in intervention clinics were
receiving treatment and those in control clinics received
a health education leaflet. At the clinic level all consecu-
tive new and retreatment TB patients were systematically
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mid- October 2011.
Blinding
Participants (clinic staff members and TB patients) were
not blinded to their intervention or control status. How-
ever, to protect against information biases in the reporting
of alcohol use and TB treatment adherence behaviour, the
data collection team who assessed the outcomes were
blinded to the clinic’s status as intervention or control
group.
Procedure
Universal screening of all new tuberculosis and retreat-
ment patients was used where all consecutive patients vis-
iting the public primary health care facility were screened
for alcohol misuse and offered a brief counselling inter-
vention if they met the criteria for misuse of alcohol. A
health care provider who identified a new or retreatment
TB patient (within one month of treatment initiation) in-
formed the patient about the study and referred the pa-
tient for participation if interested. A research assistant
asked for consent from patients attending the public pri-
mary care facility to participate in stage 1 of the study, i.e.
screening or baseline assessment using the AUDIT ques-
tionnaire. To increase the reliability of the AUDIT, re-
searchers have suggested locating alcohol consumption
within the context of other health-related behaviours [25].
The interviewer administered questionnaire, therefore,
included questions on mental and physical health status,
tobacco use and chronic diseases. The research assistant
was not involved in delivering the brief counselling inter-
vention. All participants underwent the initial assessment
and the research assistant scored the results of the alcohol
test section of the questionnaire. Tuberculosis patients
who scored 8 or more for men and 7 or more for women
on the AUDIT questionnaire after the screening (risky
drinkers) were then approached by the research assistant
for a second informed consent for enrolment in stage 2,
the intervention study. For patients included in the
study, the research assistant referred the patient to a
clinic lay counsellor who carried out the intervention
(experimental = brief counselling intervention or control =
provision of health education leaflet) for all the participants
during the same visit. Thereafter patients were scheduled
for follow-up sessions at 3 and 6 months at the health
facility, and the follow-up assessments were conducted by
the research assistant. The experimental brief intervention
included a brief counselling intervention on alcohol risk
reduction consisting of two sessions, the first immediately
after alcohol screening and the second within a month
thereafter. In the control condition the clinic lay coun-
sellor provided an alcohol education leaflet. Sampling
occurred throughout all hours of clinic operation overa 6 months period from mid March 2011 to mid October
2011. Research assistants conducted follow-up interviews
at 3 and 6 months following baseline assessment at sched-
uled clinic visits. Several attempts were made to follow-up
participants. Firstly, HSRC co-ordinators visited the clinics
to access participants fieldwork records with permission
of the professional staff in an attempt to get contact details
of participants. Secondly, fieldworkers did home visits
where no telephone numbers were available for partici-
pants. Finally, a special team of research assistants were
employed to make direct calls to both fieldworkers and
participants to help find participants to schedule appoint-
ments. Participants received Rand 60 (8.5 US$) transport
reimbursement at 6-month follow-up. Ethical approval
was obtained from the Human Sciences Research Council
Research Ethics Committee (Protocol REC No.1/16/02/
11). The Department of Health in South Africa has also
provided approval for this study. Consent to participate
was obtained in a 2-stage process. Research assistants ini-
tially asked for informed consent to conduct a health
screen and collected basic information and checked eligi-
bility to take part. No identifiable information was col-
lected at this stage. Those patients who had a positive
score on the AUDIT (alcohol risk score), had the study
explained to them verbally and in writing (using the pa-
tient information sheet). Informed consent was obtained
at this second stage which included permission to give
the contact details to the research staff, participate in
the experimental or control condition and follow up
after 3 and 6 months by the research assistant and pro-
vide permission to medical file information.
Screening and baseline assessment
To identify drinking and other health behaviours, in-
terviews with potential study volunteers were conducted
by trained research assistants using a standardized ques-
tionnaire. The 10-item AUDIT [23] assessed alcohol
consumption level (3 items), symptoms of alcohol depend-
ence (3 items), and problems associated with alcohol use
(4 items). Responses to items in the AUDIT were rated
on a 4-point Likert scale from 0 to 4, for a maximum
score of 40 points. Higher AUDIT scores indicate more
severe levels of risk: a score of 8 or more indicates a
tendency for problematic drinking, and a score of 20 or
above probable alcohol dependence [26]. Heavy episodic
drinking is defined as the consumption of six standard
drinks (10 g alcohol) or more on a single occasion [26]. In
South Africa a standard drink is 12 g alcohol. Because
AUDIT is reported to be less sensitive at identifying
risk drinking in women [17], the cut-off points of binge
drinking for women (4 units) were reduced by one unit
as compared with men (5 units), as recommended by
Freeborn and others [17]. The AUDIT has been validated
in HIV patients in South Africa showing excellent sensi-
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ence/abuse (sensitivity, 100% and correctly classified 79%
of individuals who did not have alcohol abuse or depend-
ence) [27] and among TB and HIV patients in primary
care in Zambia demonstrating good discriminatory ability
in detecting MINI-defined current AUDs (AUDIT = 0.98
for women and 0.75 for men) [28]. To comply with the
timeline of this study, all subjects were asked for their
alcohol consumption in the previous 3 months rather
than in the past 12 months.
Socioeconomic characteristics
A researcher-designed questionnaire was used to record
information on participants’ age, gender, educational
level, marital status, income, employment status, dwelling
characteristics and residential status. Poverty was assessed
with 5 items on the availability or non-availability of shel-
ter, fuel or electricity, clean water, food and cash income
in the past week. Response options ranged from 1 = “Not
one day” to 4 = “Every day of the week”. Poverty was
defined as higher scores on non-availability of essential
items. The total score ranged from 5 to 20, 5 = being low,
6-12 =medium and 13-20 = high poverty. Cronbach alpha
for this poverty index was 0.89 in this sample.
Tobacco use
Two questions were asked about the use of tobacco
products. 1) Do you currently use one or more of the
following tobacco products (cigarettes, snuff, chewing
tobacco, cigars, etc.)? Response options were “yes” or
“no”. 2) In the past month, how often have you used one
or more of the following tobacco products (cigarettes,
snuff, chewing tobacco, cigars, etc.)? Response options
were once or twice, weekly, almost daily and daily.
TB treatment status, HIV status and antiretroviral
treatment were assessed by self-report and from medical
information. Patients were also asked about a list of
chronic and other illness conditions they had been diag-
nosed with such as diabetes.
Interventions
Health education leaflet
All the patients randomized and allocated to the control
group completed the baseline measures and received a
health education leaflet on responsible drinking.
Brief counselling
The patients randomized and allocated to the interven-
tion arm completed baseline measures and received brief
counselling for alcohol reduction intervention. The goals
for brief counselling were as follows: 1) To identify any
alcohol- related problems mentioned in the interview, 2)
To introduce the sensible drinking leaflet, emphasis the
idea of sensible drinking limits, and make sure thatpatients realize that they are in the risk drinking category,
3) To provide feedback on the relationship between alco-
hol and TB treatment [21,29], 4) To work through the first
3 sections of the problem solving manual while men-
tioning the value of reviewing the other sections, 5) To de-
scribe drinking diary cards, 6) To identify a helper, and 7)
To plan a follow-up counselling session. The Information-
Motivation-Behavioural Skills (IMB) Model was used in
the study to guide the alcohol reduction intervention. The
IMB model [30-32] proposes that information about al-
cohol misuse and methods of reducing and preventing
harmful and/or hazardous drinking is a necessary precur-
sor to risk reduction. Motivation to change, however, also
directly affects whether one acts on information about risk
and risk reduction. Finally, the IMB model holds that
behavioural skills related to preventive actions represent
a final common pathway for information and motivation
to result in alcohol risk behaviour change. The IMB model
posits that information and motivation activate behav-
ioural skills to ultimately enact risk reduction behaviours.
The IMB model also shows that information or motivation
alone can have direct effects on some preventive be-
haviour, such as when information about risky alcohol
drinking prompts drinking at moderate levels or to stop
drinking more detail, [33]. The intervention was com-
posed of two scheduled sessions: on Day 1 and within one
month after the baseline evaluation. Each session com-
prised 15–20 minutes of counselling.
Counsellor training and intervention quality assurance
The intervention counsellors consisted of lay HIV coun-
sellors from the study clinics who spoke the predomin-
ant languages, namely English, Afrikaans, i-Zulu, i-Xhosa
and Tswana, in the respective areas. These counsellors
delivered the interventions to the participants of the
study in addition to the “treatment as usual”. The treat-
ment “as usual” consisted of the provision of standardised
short-course chemotherapy under direct observation of
treatment (DOT) for at least the initial phase of treatment
to all identified smear-positive TB cases in all study clinics
[34]. All lay counsellors and up to four nurses per study
clinic who were suitable to deliver the brief counselling
intervention received formal training (lay counsellors
3 days and nurses 2 days) and supervision prior to the
start of the study. It was agreed that the HIV lay counsel-
lors would implement the intervention and the trained
nurses will assist when necessary. The training took a
practical, systems approach, aiming to facilitate the imple-
mentation of SBI in clinic operations rather than merely
educating staff. The training curriculum contained mod-
ules addressing practical issues deemed essential to im-
plementing the programme. For early identification of
alcohol problems in public primary care the AUDIT [26]
and for the brief intervention the WHO brief intervention
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used. Both were adapted to the South African context, e.g.
in terms of standard unit of alcoholic drink and drinking
limits. The AUDIT was translated and back translated
according to scientific standard procedures [26] into four
of the major languages (Tsonga, Northern Sotho, Venda,
and Afrikaans) [16,18] and also translated into additional
languages (Xhosa, Zulu and Tswana). The self-help book-
let for patients and a hand-out on “cutting back” showing
the drinking limits and health effects of risky alcohol
consumption were also made available in the languages
relevant for the study. The AUDIT manual explains the
purpose of screening for alcohol problems in primary care,
the context of alcohol screening, the development and val-
idation of the AUDIT, administration guidelines, scoring
and interpretation. The Brief Intervention manual defines
concepts and terms, roles and responsibilities of Public
Primary Health Care, SBI: a risk management and case
finding approach, alcohol education for low-risk drinkers,
abstainers and others, and simple advice a brief counsel-
ling for risk zone drinkers, self-help booklet and training
sources. Critical administrative activities included admin-
istration and scoring of the screening instruments, as-
suring availability of patient brochures, sequencing of
interventions with treatment of presenting health prob-
lems, the essential elements of an intervention, and the
management of SBI records.
The training comprised of four elements: orientation
to the relevant practice, standardised power point pres-
entation, tape recorded simulated consultations with
trained actors and on-going clinical supervision by expe-
rienced HSRC staff. The simulated consultations were
recorded and rated by two independent clinical asses-
sors. The brief intervention counsellor was assessed for
adherence to the brief counselling protocol in addition
to their behaviour and skills using a Behaviour Change
Counselling Index [36].
Assessors submitted the ratings, comments and super-
vision points for each consultation. This information
supported clinical supervision and training until the
brief intervention counsellor reached a required stand-
ard of practice agreed by the assessors [37].
To help protect against counsellor drift (deviating
from the existing treatment intervention protocol), the
brief intervention was completely manualized and was
used to guide the counsellor through the content of the
session. Lay counsellors received bi-weekly support visits
by the project trainers during the implementation of the
project. Monthly visits were paid by research staff to the
clinics in support for the project to assist them with any
technical aspects of the counselling intervention. In
terms of control around the quality and consistency of
the implementation of the intervention, intervention
counsellors filled in a patient monitoring form for eachcounselling session conducted. It included sections on
the client’s AUDIT score, stage of change, action and
intervention plan, handing of action plan to client and
comments. A readiness ladder was used to assess a pa-
tients’ readiness to change their drinking, i.e. their stage
of change. Patients were asked to rate on a ladder from
‘not at all’, ‘a little’, ‘somewhat’, ‘very’ to ‘extremely’, “How
important is it for you to change your drinking?” Pa-
tients who score in the lower end (‘not at all’) of the
scale were classified as pre-contemplators, those who
score in the middle range (‘a little’ – ‘somewhat’) as con-
templators, and those scoring in the higher range were
considered as ready to take action. Intervention coun-
sellors were compensated with R20 (US$2.6) for each
counselling session conducted and monitoring form
completed. In addition, study fieldworkers were able to
report to their coordinators regarding any problems they
may be having in implementing the brief interventions.
Regular meetings between the researchers and the pro-
ject managers allowed for any problems to be resolved
timeously.
Outcome evaluation
A health survey questionnaire was administered in a
face-to-face interview in scheduled appointments at the
clinic was used to collect outcome information at 3 and
6 months following the baseline assessment. In addition,
medical file information was collected for HIV and TB
treatment status and outcome. Non-attenders were fol-
lowed up by telephone and home visits arranged as ne-
cessary. The primary outcome was the (1) change in the
mean score on the AUDIT in the last 3 months and the
number of AUDIT negative drinkers in the last month
of the study period compared with baseline, as measured
by the AUDIT. The secondary outcome was the success-
ful TB response, classified by WHO as cured or treat-
ment completed (versus treatment failure, defaulted,
died or transferred out to another health facility [38].
Sample size calculation
Using the Practihc Trial Protocol tool sample size is calcu-
lated with cluster size as a binary outcome based on an
average cluster size of 350, an intra-cluster correlation co-
efficient of 0.2, with 90% power and 5% significance level.
A previous review [39] found a clinically important differ-
ence in negative status on AUDIT between brief interven-
tion and controls of 13% (5% reduction in controls and
18% in brief intervention recipients). With an expected
20% AUDIT negative in the intervention and 5% in the
control, a minimum of 200 sample per group (total 400),
with 20 clusters per group, would be needed. Assuming
a loss to follow-up of 40%, the sample size was inflated
to 280 per group (total 560). As initially only new TB
patients were considered in the trial but later new
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sample size was doubled to 1120.
Data management and analyses
Data were captured by dedicated data capturers. Data
cleaning and data verification was supervised by key pro-
ject staff, including the principal investigator and meth-
odologist. The verification process included double data
entry of all questionnaires and its fields, doing pro-
grammed range checks by computer to identify outlying
values, checking for missing values, and checking for
inconsistencies in the data. Cluster-specific methods of
data analysis (Generalized Estimating Equations) were
used because we randomized clinics rather than patients.
Data were analysed using STATA Version 11.
Intention to treat
The principle of the statistical analysis was intention to
treat. It was applied to the two hierarchical levels of the
trial: the clinics randomized at the cluster level and the
patients recruited within each of these units.
Clinic level In all 36 units randomized were included in
the analysis. Units were analysed according to the inter-
vention group allocated at randomization. The stratifica-
tion used for the randomization of clinics (TB caseload
and type of facility) were taken into account in the
analysis.
Patient level In all 853 patients recruited to the study
were used in the analysis of the primary and secondary
outcomes. Patients were analysed as a member of the
clinic in which he/she was recruited.
Analysis approach
The primary outcome was measured at three time points:
baseline, three and at six months. If a patient dropped out,
and is not present on the day of the interview or refuses
to answer questions the primary outcome at the end
point of the trial was missing. Therefore, except for the
baseline measurement, no post-randomization informa-
tion was available for these participants. The extent of
the missing component was 29% at six months. The
method used to take account of the stratified cluster
trial design, the repeated binary and linear nature of
the primary and secondary outcome (Risky drinking,
TB treatment outcome) and the missing data at follow-up
is a generalized estimation equations (GEE) approach [40].
The total AUDIT score had to be log-transformed [x’ = log
(x + 1)] beforehand, with the aim of making the distribu-
tion less skewed. The logarithmically transformed AUDIT
score was compared between groups by Student t test. Be-
cause the randomization had been on clinic level, and to
correct for baseline differences between the two groups,multilevel logistic regression was performed for binominal,
and multilevel linear regression for continuous variables.
Estimated treatment effects are reported with 95% confi-
dence intervals. Descriptive statistics were calculated
for baseline and follow-up.
Results
Screening and randomization
Figure 1 summarizes patient identification, recruitment,
randomization, and follow-up numbers. We identified
4955 public primary care TB patients of which 3684
screened negative for alcohol, 51 refused to participate
and 24 were found ineligible, resulting in 1196 patients
across 40 primary care clinics. Of the 4880 screened for
alcohol and agreed to participate in the trial 1196
(24.6%) tested positive for the AUDIT. Participants in
clinics were randomized into 20 control and 20 interven-
tion clinics using the clinic as a unit of randomization to
455 patients in the control group and 741 in the interven-
tion group. As illustrated in Figure 1, response rates were
higher in the intervention than in the control group at
both follow-ups. At the 3-month follow-up, response rates
for the control and intervention were 39% and 54%, re-
spectively, and at 6 months, the control and intervention
group response rates were 59% and 79%, respectively. In
the control group 41% did not complete the last follow-up
survey (i.e., the dropout rate was 41%); in the intervention
group, 21% did not complete the last follow-up survey.
The main difference between groups was in the dropout
rate (percentage of participants that did not complete the
last follow-up survey): 21% in the intervention group ver-
sus 41% in the control group.
Attrition analyses were conducted to check for differ-
ential attrition by examining the condition by dropout
interactions at baseline. Dropout was significantly related
to the condition (P < 0.001) and poverty (P = 0.003), indi-
cating a relationship between these variables and dropout
status depending on condition: 21% in the intervention
group versus 41% in the control group dropped out
and the poverty index was 9.9 in the intervention versus
8.9 in the control group. Dropout was not related to gen-
der (P = 0.308), age (P = 0.078), education (P = 0.866),
AUDIT score (P = 0.958), AUDIT (7–40) (P = 0.516),
AUDIT (7–19) (P = 0.952), AUDIT (20–40) (P = 0.918),
heavy episodic drinking (P = 0.192), daily or almost daily
tobacco use (P = 0.929), HIV status (P = 0.488), and TB
new or retreatment patient (P = 0.082).
Brief intervention implementation fidelity analysis
Assessment of intervention fidelity via the patient moni-
toring forms found that the intervention was delivered
with sufficient fidelity. In 75% of the intervention ses-
sions, the lay counsellors implemented at least 6 of the 7
requisite intervention steps (including, e.g., to describe
42 clinics:  4955 participants
40 clinics: 1196 participants in Trial 
20 clinics: 455 received health 
education leaflet (Average cluster 
size: 23, range 1-63 
20 clinics: 741 received the 
intervention- IMB (Average cluster 
size: 37, range 1-112 
176 (39%) patients attended 3- 
month follow-up (from 12 
clinics) (Average cluster size: 15, 
range 1-39) 
400 (54%) patients attended  
3-month follow-up (from 18 clinics) 
(Average cluster size: 
22, range 1-107 
2 clinics excluded: no one 
screened positive
341 patients missed at 
3-month follow-up
279 patients missed at 
3-month follow-up
269 (59%) patients attended 6- 
month follow-up 
(from 17 clinics) 
(Average cluster size: 
23, range 1-63 
584 (79%) patients attended 6- month 
follow-up 
(from 19 clinics) 
(Average cluster size: 
23, range 1-63 
186 patients missed at  
6-month follow-up 
No consent: n=2 
Died: n=6 
Transferred: n=12 
Not found/reached: n=166 
157 patients missed at  
6-month follow-up 




Analyzed: 17 clinics; N=269 
(59%) participants 
Analyzed: 19 clinics; N=584 (79%) 
participants 
Figure 1 Flow-chart of clinics and participants in the trial.
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http://www.biomedcentral.com/1471-2458/13/699drinking diary cards, stage of change, action and inter-
vention plan). In addition, it was found that in 96% of
the cases of brief intervention, only one session was
conducted despite having scheduled a follow-up ses-
sion, and in 4% of cases two sessions. Further analysis
of the monitoring form assessing the stage of change in
the intervention group found that 7.4% were at the
precontemplation, 38.9% at the contemplation, 34%
preparation and 19.7% at the action stage.Participant characteristics
Table 1 summarizes demographic, health variables and
alcohol-related characteristics of the study participants.
Overall, the study sample was 74.3% male, averaged
36.7 years of age, 19.3% had grade 12 or more educa-
tion and 21.8% scored high on the poverty index. With
regard to health variables, 19.9% were TB retreatment
and 80.1% new TB patients, 54.2% were HIV positive,
73.2% were high risk drinkers and 26.8% were probable
alcohol dependent. The mean AUDIT score was 15.7
(see Table 1).Drinking and TB treatment outcomes
There were significant reductions in the AUDIT score
(AUDIT total score, hazardous or harmful drinking or
alcohol dependence, hazardous drinking, alcohol de-
pendence and heavy episodic drinking) over time across
treatment groups. Among the 853 (71%) patients who
also attended the 6-month follow-up session, the fre-
quency of positive screening results at baseline/follow-
up were100/ 21.2% for the AUDIT (P < 0.001) for the
control group and 100/16.8% (P < 0.001) for the inter-
vention group. The intervention effect on the AUDIT
score was statistically not significant. The intervention
effect was also not significant for hazardous or harmful
drinkers and alcohol dependent drinkers (AUDIT: 7–40),
alcohol dependent drinkers and heavy episodic drinking,
while the control group effect was significant for hazard-
ous drinkers (AUDIT: 7–19) (P = 0.035). Further, there
was also no significant intervention effect for daily or
almost daily tobacco users and at 6-month follow-up the
intervention group did not significantly differ to the con-
trol group in terms of TB treatment cure or completion
rate (see Table 2).
Table 1 Baseline descriptive information
Variables Control Intervention
N = 455 (%) N = 741 (%)
Socio-demographic variables
Gender (N,% male) 328 (73.4) 545 (74.9)
Age (M, SD) 35.9 (10.8) 37.2 (11.0)
Education
Grade 7 or less 134 (29.9) 251 (34.5)
Grade 8-11 237 (52.5) 329 (45.2)
Grade 12 or more 79 (17.5) 148 (20.3)
Poverty index (5–20)
Low (5) 134 (31.0) 191 (28.2)
Medium (6–12) 235 (54.4) 307 (45.3)
High (13–20) 63 (14.6) 179 (26.4)
Health variables
Perceived health status
Excellent 47 (10.4) 55 (7.5)
Very good 68 (15.0) 60 (8.2)
Good 133 (29.4) 282 (38.4)
Fair 130 (28.8) 254 (34.6)
Poor 74 (16.4) 83 (11.3)
AUDIT total (M,SD) 14.2 (6.0) 16.5 (6.5)
AUDIT (7–19) 369 (80.7) 507 (68.6)
AUDIT (20–40) 88 (19.3) 232 (31.4)
New TB patient 344 (78.0) 592 (81.3)
Retreatment TB patient 97 (22.0) 136 (18.7)
Daily or almost daily tobacco use 171 (38.1) 267 (39.8)
HIV positive 210 (46.5) 435 (59.0)
HIV negative 215 (47.6) 245 (33.2)
HIV unknown 27 (6.0) 56 (7.6)
On antiretroviral therapy 91 (29.8) 142 (32.3)
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To our knowledge, this is the first randomized trial to
evaluate the effectiveness of a brief intervention for haz-
ardous and harmful drinkers with tuberculosis in public
primary care clinics in South Africa. The trial was
conducted in 40 public primary care clinics including
sites in urban and rural areas in three different districts
in three different provinces in South Africa with a high
TB disease burden. These diverse settings strengthen the
generalizability of the findings.
Self-reported outcome data suggest that the provision
of a health education leaflet can help reduce levels of
hazardous and harmful alcohol use in those TB patients
attending public primary care in South Africa. From
baseline to 3- and 6-month follow-up, alcohol consump-
tion declined significantly in both intervention andcontrol groups. The intervention effect was, however,
not statistically significant on the AUDIT score, hazard-
ous or harmful drinkers and alcohol dependent drinkers
(AUDIT: 7–40), alcohol dependent drinkers and heavy
episodic drinking, while the control group effect was sig-
nificant for hazardous drinkers (AUDIT: 7–19).
The significant reduction of hazardous or harmful al-
cohol use and possible alcohol dependence found in our
trial in the control or no-treatment group has at least
three possible explanations, including 1) the intervention
effect of alcohol screening/follow-up and provision of
health education leaflet on sensible alcohol drinking, 2)
the intervention effect of standard care (nurses provide
advice on alcohol drinking) and 3) natural history changes
in drinking over time in the course of TB treatment.
McCambridge and Kypri [41] reviewed that simply an-
swering questions on drinking in brief intervention trials
appears to alter subsequent self-reported behaviour. This
potentially generates a bias by exposing non-intervention
control groups to an integral component of the interven-
tion. The effects of brief alcohol interventions may thus
have been consistently under-estimated. Based on the
assessment of stage of change in alcohol drinking by the
lay counsellors in the intervention group, it was found
that already a large proportion of the patients (53.7%)
have been in the preparation or action stage of change,
according to the IMB model. In addition, qualitative
information collected in a sub-sample of follow-up in-
terviews seemed to confirm the reduction of alcohol
use due to the health care provider’s advice and due to
illness and TB treatment condition. Other studies e.g.,
[42] seem to have shown a reduction of alcohol use
with the initiation of ART, which could be similar with
the initiation to TB treatment.
Further, the study found that there was no significant
difference in TB treatment cure or completion rate
between intervention and control group at 6 months
follow-up. It is possible that there are factors, such as
enabling or disabling individual, familial and commu-
nity-level conditions, which were not taken into account
nor measured in the study. In addition, the study did
not find a significant reduction of tobacco use in the
intervention compared to the control group, which is in
line with a recent review [43] that found brief alcohol
interventions do not also reduce cigarette smoking, and
it appears unlikely that there exist other important sec-
ondary effects.
Studies of brief intervention delivery in primary care
by lay counsellors are much rarer than by health care
professionals. Lay counsellor delivered brief alcohol in-
terventions with TB patients seems to be feasible to im-
plement with fidelity in the South African primary care
setting, as found in the context of HIV risk reduction
counselling in South Africa [44].
Table 2 Alcohol-related outcome measures at baseline, 3-month and 6-month follow-up and TB treatment outcome
at 6-month follow-up
Variables Time Control Intervention OR* (95% CI) P-value ICC (SE)
Adjusted for cluster
AUDIT total (M,SD) Baseline 14.2 (6.1) 16.5 (6.5) 0.91 (0.78-1.07) 0.264 0.13 (0.04)
3 months 4.0 (5.9) 5.0 (6.1)
6 months 3.6 (6.2) 2.4 (4.8)
AUDIT (7–40) High risk or alcohol dependence Baseline 455 (100) 741 (100) 0.70 (0.41-1.19) 0.186 0.11 (0.03)
3 months 37 (21.0) 139 (34.8)
6 months 57 (21.2) 98 (16.8)
AUDIT (7–19) High risk (N,%) Baseline 367 (80.7) 507 (68.4) 0.64 (0.43-0.97) 0.035 0.07 (0.02)
3 months 33 (18.8) 126 (31.5)
6 months 45 (16.7) 91 (15.6)
AUDIT (20–40) Alcohol dependence (N,%) Baseline 88 (19.3) 233 (31.4) 1.39 (0.75-2.56) 0.296 0.09 (0.03)
3 months 4 (2.3) 13 (3.2)
6 months 12 (4.5) 7 (1.2)
Heavy episodic drinking1 (weekly+) (N,%) Baseline 131 (29.0) 331 (45.2) 0.96 (0.46-2.02) 0.921 0.22 (0.06)
3 months 11 (9.6) 23 (10.4)
6 months 13 (11.6) 16 (10.6)
Daily or almost daily tobacco use (N,%) Baseline 171 (39.0) 278 (40.8) 1.12 (0.67-1.89) 0.662 0.09 (0.03)
6 months 71 (31.8) 93 (18.6)
TB treatment outcomes (N,%)2 6 months 195 (53.6) 289 (45.9)
Cure 76 (20.9) 135 (21.5)
Complete 22 (6.0) 29 (4.6)
Failure 65 (17.9) 155 (24.6)
Default 6 (1.6) 21 (3.3)
Died 12 (3.2) 44 (6.5)
Transfer out
TB treatment cure or completion 6 months 271 (74.5) 424 (67.4) 0.93 (0.46-1.88) 0.840 0.15 (0.5)
1For men 5 or more and for women 4 or more drinks on one occasion.
2 TB treatment outcomes defined as from WHO classification [35] was not complete (N = 1049; 88%) due to various reasons including missing codebook of
fieldworker lost, the incorrect recording of names, names could not be found in clinic register, and clinic register lost.
OR Odds Ratio, ICC Intracluster correlation coefficient, SE Standard Error.
*Odds ratios from regression models were adjusted for age, sex, and baseline alcohol use disorders identification test score.
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Our study has several limitations, including the loss of
patients at each follow-up point. Despite randomization
there were baseline differences between the two groups
on several covariate measures. This may be due to the
relatively large variation of the sample size on the level
of group assignment. Although we controlled for these
differences, we cannot exclude that there are additional
unmeasured baseline differences that confound the ef-
fect, a fact that reduces internal validity of the study.
The high dropout rate in the control compared to the
intervention group represents a threat to the validity of
the findings of this study and the most likely source of
bias. Further, alcohol use was only assessed by self-
report. The consensus in the research community that
self-reported alcohol consumption was valid derivesmainly from conclusions drawn from studies undertaken
in treatment contexts [45]. It is not clear whether in-
fluences on the validity of self-report may be different in
South Africa. Bias in alcohol consumption may have
resulted from self-reported outcome measures. Future
studies should consider assessing alcohol consumption
by both self-report and objective measures, such as
blood alcohol level. Further, the study only assessed
short-term intervention effects (6 months) and longer
term assessments (12 months) would be needed, espe-
cially because TB patients after having been cured may
start drinking again.
Conclusion
In this rigorously conducted trial, we succeeded in
implementing a lay counsellor led brief alcohol inter-
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http://www.biomedcentral.com/1471-2458/13/699vention in a general clinic-based sample of hazardous and
harmful drinkers. The short duration of the brief interven-
tion makes it a realistic candidate for use in primary health
care. Based on this study evidence the effectiveness of
brief interventions in TB public primary care patients is
still inconclusive. The reduced alcohol consumption of
the control group may have resulted from the screening
assessment at baseline, the provision of the health edu-
cation leaflet on sensible drinking and the natural history
of alcohol misuse in the course of TB treatment. More
studies are needed to explore the effects of brief alcohol
interventions with tuberculosis patients in primary care
settings. The results suggest that alcohol screening and
the provision of a health education leaflet on sensible
drinking performed at the beginning of anti-tubercu-
losis treatment in public primary care settings may be
effective in reducing alcohol consumption.
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